Published in Eur Heart J on March 10, 2008
Intelligence in youth and all-cause-mortality: systematic review with meta-analysis. Int J Epidemiol (2010) 3.08
How Does Cardiovascular Disease First Present in Women and Men? Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People. Circulation (2015) 1.72
Elevated cardiac troponin I and functional recovery and disability in patients after aneurysmal subarachnoid hemorrhage. Am J Crit Care (2010) 1.45
Sex differences in the endothelial function of untreated hypertension. J Clin Hypertens (Greenwich) (2012) 1.39
The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart (2009) 1.28
Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag (2009) 1.22
Interaction of sleep quality and psychosocial stress on obesity in African Americans: the Cardiovascular Health Epidemiology Study (CHES). BMC Public Health (2010) 1.19
The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol (2010) 1.09
Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol (2009) 1.08
Health Promoting Behaviors in a Population-based Sample of Middle-aged Women and its Relevant Factors in Yazd, Iran. Int J Prev Med (2012) 1.04
The relationship between various measures of obesity and arterial stiffness in morbidly obese patients. BMC Cardiovasc Disord (2011) 1.04
Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation (2014) 1.03
Prevention & control of CVD in women & children in India. Indian J Med Res (2013) 1.03
Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry. BMC Cardiovasc Disord (2011) 1.01
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev (2016) 0.96
Age-specific gender differences in early mortality following ST-segment elevation myocardial infarction in China. Heart (2014) 0.95
eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex. Am J Physiol Heart Circ Physiol (2010) 0.95
Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America. Glob Heart (2016) 0.92
Food choices and coronary heart disease: a population based cohort study of rural Swedish men with 12 years of follow-up. Int J Environ Res Public Health (2009) 0.87
Vascular disease in diabetic women: Why do they miss the female protection? Exp Diabetes Res (2012) 0.86
Age- and sex-specific causal effects of adiposity on cardiovascular risk factors. Diabetes (2015) 0.86
Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. J Clin Endocrinol Metab (2008) 0.85
Lymphocytes of type 2 diabetic women carry a high load of stable chromosomal aberrations: a novel risk factor for disease-related early death. Diabetes (2008) 0.84
Physical activity in older men: longitudinal associations with inflammatory and hemostatic biomarkers, N-terminal pro-brain natriuretic peptide, and onset of coronary heart disease and mortality. J Am Geriatr Soc (2014) 0.84
A TagSNP in SIRT1 gene confers susceptibility to myocardial infarction in a Chinese Han population. PLoS One (2015) 0.82
Cardiac Syndrome X: update 2014. Cardiol Clin (2014) 0.81
Gender and Age Differences in Short- and Long-Term Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.81
Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study. Cardiovasc Diabetol (2015) 0.80
Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study. Br J Gen Pract (2015) 0.80
Gender Based Differences in Risk Factor Profile and Coronary Angiography of Patients Presenting with Acute Myocardial Infarction in North Indian Population. J Clin Diagn Res (2016) 0.79
Retinal vein occlusion and the risk of acute myocardial infarction development: a 12-year nationwide cohort study. Sci Rep (2016) 0.79
Assessment of Risk Factors in Patients With Myocardial Infarction. Glob J Health Sci (2015) 0.79
Gene-specific DNA methylation profiles and LINE-1 hypomethylation are associated with myocardial infarction risk. Clin Epigenetics (2015) 0.79
The LRP6 rs2302685 polymorphism is associated with increased risk of myocardial infarction. Lipids Health Dis (2014) 0.79
Association of genetic variations in the Wnt signaling pathway genes with myocardial infarction susceptibility in Chinese Han population. Oncotarget (2016) 0.78
Risk factors for myocardial infarction in women and men. Eur Heart J (2009) 0.78
Myocardial infarction thought to be provoked by local epinephrine injection during endoscopic submucosal dissection. J Clin Med Res (2011) 0.78
Sex differences in independent factors associated with coronary artery disease. Wien Klin Wochenschr (2014) 0.78
Acute coronary syndromes in young women - the scale of the problem and the associated risks. Kardiochir Torakochirurgia Pol (2015) 0.78
Endothelial biology in the post-menopausal obese woman. Maturitas (2011) 0.78
Alcohol intake and risk of acute coronary syndrome and mortality in men and women with and without hypertension. Eur J Epidemiol (2011) 0.78
Ischemia/Reperfusion. Compr Physiol (2016) 0.78
Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat. PLoS One (2015) 0.77
Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes. Atherosclerosis (2015) 0.77
Protective Effect of Creatine Elevation against Ischaemia Reperfusion Injury Is Retained in the Presence of Co-Morbidities and during Cardioplegia. PLoS One (2016) 0.77
Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy. Nat Rev Cardiol (2015) 0.77
Lifestyle factors, medication use and risk for ischaemic heart disease hospitalisation: a longitudinal population-based study. PLoS One (2013) 0.77
Gender differences related to the presence of atrial fibrillation in older hypertensive patients. World J Cardiol (2013) 0.77
Excess cardiovascular risk in diabetic women: a case for intensive treatment. Curr Hypertens Rep (2015) 0.77
Primary prevention of heart failure. ISRN Cardiol (2012) 0.76
Sex Differences in Correlates of Intermediate Phenotypes and Prevalent Cardiovascular Disease in the General Population. Front Cardiovasc Med (2015) 0.76
Leisure time physical activity and long-term cardiovascular and cancer outcomes: the Busselton Health Study. Eur J Epidemiol (2014) 0.76
The impact of different anthropometric measures on sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension in patients with type 2 diabetes. Endocrinol Metab (Seoul) (2013) 0.76
Disparities in Prevalence of Cardiometablic Risk Factors in Rural, Urban-Poor, and Urban-Middle Class Women in India. PLoS One (2016) 0.76
Plasma Efavirenz Concentrations Are Associated With Lipid and Glucose Concentrations. Medicine (Baltimore) (2016) 0.76
Sex differences in the outcomes of peripheral arterial disease: a population-based cohort study. CMAJ Open (2016) 0.75
Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models. Mediators Inflamm (2017) 0.75
The Association of Family History of Premature Cardiovascular Disease or Diabetes Mellitus on the Occurrence of Gestational Hypertensive Disease and Diabetes. PLoS One (2016) 0.75
Computed tomography coronary angiography in patients with acute myocardial infarction and normal invasive coronary angiography. BMC Cardiovasc Disord (2016) 0.75
Self-Management of Heart Disease in Older Adults. Home Health Care Serv Q (2015) 0.75
Myocardial infarction in the Wisconsin Longitudinal Study: the interaction among environmental, health, social, behavioural and genetic factors. BMJ Open (2017) 0.75
Conflicts of interest in medicine and science. Eur Heart J (2012) 0.75
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation (2017) 0.75
Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study. PLoS One (2016) 0.75
Are there differences in LDL-C target value attainment in Austrian federal states? Yes! Wien Med Wochenschr (2013) 0.75
Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit. Singapore Med J (2014) 0.75
Myocardial revascularization: do age and sex matter? J Thorac Dis (2016) 0.75
Why do men and women differ in their risk of myocardial infarction? Eur Heart J (2008) 0.75
The effects of oestrogens and their receptors on cardiometabolic health. Nat Rev Endocrinol (2017) 0.75
Chronic exposure to low doses of HgCl2 avoids calcium handling impairment in the right ventricle after myocardial infarction in rats. PLoS One (2014) 0.75
Different patterns of association between education and wealth with non-fatal myocardial infarction in Tehran, Iran: A population-based case-control study. Med J Islam Repub Iran (2015) 0.75
Novel cardiovascular risk markers in women with ischaemic heart disease. Cardiovasc J Afr (2014) 0.75
Sex-specific factors in microvascular angina. Can J Cardiol (2014) 0.75
Anxiety Level and Cardiac Autonomic Modulations in Coronary Artery Disease and Cardiac Syndrome X Patients. PLoS One (2017) 0.75
PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease. Lipids Health Dis (2017) 0.75
Resting blood pressure reductions following isometric handgrip exercise training and the impact of age and sex: protocol for a systematic review. Syst Rev (2015) 0.75
Physical Activity and Survival among Long-term Cancer Survivor and Non-Cancer Cohorts. Front Public Health (2017) 0.75
Are Additional Lipid Measures Useful? Integr Med (Encinitas) (2008) 0.75
Therapy for stable angina in women. P T (2012) 0.75
Interval and continuous aerobic exercise training similarly increase cardiac function and autonomic modulation in infarcted mice. J Exerc Rehabil (2017) 0.75
Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004-2014. Cardiovasc Diabetol (2017) 0.75
Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases. Heart Fail Rev (2017) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med (1991) 16.19
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15
Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med (2012) 10.09
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.02
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Effect of ramipril on the incidence of diabetes. N Engl J Med (2006) 9.69
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med (2009) 8.73
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet (2011) 8.49
Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83
Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med (2014) 7.54
Spironolactone for heart failure with preserved ejection fraction. N Engl J Med (2014) 7.48
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA (2005) 7.35
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet (2010) 7.08
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA (2005) 6.81
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med (2012) 6.42
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Glycemic control and excess mortality in type 1 diabetes. N Engl J Med (2014) 6.39
Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA (2007) 6.38
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med (2012) 6.16
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med (2010) 6.05
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet (2006) 5.85
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation (2002) 5.79
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. N Engl J Med (2015) 5.31
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (2008) 5.27
Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med (2006) 5.24
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA (2013) 5.19
Use of ramipril in preventing stroke: double blind randomised trial. BMJ (2002) 4.91
Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88
Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med (2014) 4.86
Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol (2007) 4.74
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med (2010) 4.73
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med (2013) 4.67
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Engl J Med (2015) 4.56
Defining obesity cut points in a multiethnic population. Circulation (2007) 4.42
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol (2005) 4.40
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37